The list of study investigators was previously published in Nauck et al. (see Reference #9).
Safety and efficacy of treatment with sitagliptin or glipizide in patients with type 2 diabetes inadequately controlled on metformin: a 2-year study
Article first published online: 4 MAR 2010
© 2010 Blackwell Publishing Ltd
International Journal of Clinical Practice
Volume 64, Issue 5, pages 562–576, April 2010
How to Cite
Seck, T., Nauck, M., Sheng, D., Sunga, S., Davies, M. J., Stein, P. P., Kaufman, K. D., Amatruda, J. M. and for the Sitagliptin Study 024 Group (2010), Safety and efficacy of treatment with sitagliptin or glipizide in patients with type 2 diabetes inadequately controlled on metformin: a 2-year study. International Journal of Clinical Practice, 64: 562–576. doi: 10.1111/j.1742-1241.2010.02353.x
ClinicalTrials.gov: NCT00094770 (Sitagliptin Study 024) Clinicalstudyresults.org: JanuviaTM– Merck Protocol Number 024.
Disclosures Michael Nauck, has received honoraria from Merck & Co., Inc. for memberships on the advisory boards and for speaking on subjects related to sitagliptin, DPP-4 inhibitors and incretins in general. He has also received honoraria from Bristol-Myers-Squibb, GlaxoSmithKline, Merck (Darmstadt), Novartis, Probiodrug and Roche for consultations and speaking on topics closely related to sitagliptin and other DPP-4 inhibitors. Thomas Seck, Danielle Sheng, Sheila Sunga, Michael J. Davies, Peter Stein, Keith Kaufman and John Amatruda were employees of Merck & Co., Inc. during the conduct of this study.
- Issue published online: 10 MAR 2010
- Article first published online: 4 MAR 2010
- Paper received December 2009, accepted January 2010
Options for accessing this content:
- If you are a society or association member and require assistance with obtaining online access instructions please contact our Journal Customer Services team.
- If your institution does not currently subscribe to this content, please recommend the title to your librarian.
- Login via other institutional login options http://onlinelibrary.wiley.com/login-options.
- You can purchase online access to this Article for a 24-hour period (price varies by title)
- If you already have a Wiley Online Library or Wiley InterScience user account: login above and proceed to purchase the article.
- New Users: Please register, then proceed to purchase the article.
Login via OpenAthens
Search for your institution's name below to login via Shibboleth.
Registered Users please login:
- Access your saved publications, articles and searches
- Manage your email alerts, orders and subscriptions
- Change your contact information, including your password
Please register to:
- Save publications, articles and searches
- Get email alerts
- Get all the benefits mentioned below!
Patients and/or caregivers may access this content for use in relation to their own personal healthcare or that of a family member only. Terms and conditions will apply.